Portfolio Holdings Detail for ISIN IE00BD93YH54
Stock Name / FundiShares Edge S&P 500 Minimum Volatility UCITS ETF USD (Dist)
IssuerBlackrock
Entity holding fund iShares VI Public Limited Company
Entity Type
Entity LEI 549300VML6THE3JJOS76
ETF TickerSPMD(USD) LSE
ETF TickerSPMD.LS(USD) CXE
ETF TickerSPMD.L(GBP) LSE

Holdings detail for MRK

Stock NameMarks Electrical Group PLC
TickerMRK(GBX) LSE
TYPECommon Stock
CountryUK
ISINGB00BM8Q5G47
LEI2138007KN8TKPIXIQE92
TickerMRK(EUR) F

Show aggregate MRK holdings

News associated with MRK

Surprising Analyst 12-Month Target For FDL
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-22 08:04:45
IWD, JNJ, MCD, MRK: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 Value ETF (Symbol: IWD) where we have detected an approximate $565.9 million dollar inflow -- that's a 0.9% increase week over w - 2025-09-18 13:26:06
Daiichi Sankyo, Merck Say Raludotatug Deruxtecan Granted Breakthrough Therapy Designation
(RTTNews) - Daiichi Sankyo Company Limited (DSKYF) and Merck & Co Inc. (MRK) said on Monday that the U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation for their raludotatug deruxtecan for the treatment of adults with platinum-resistant epithelia - 2025-09-15 08:43:59
Peter Lynch Detailed Fundamental Analysis - MRK
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-12 10:32:51
Guru Fundamental Report for MRK - Peter Lynch
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-11 10:33:21
Notable ETF Inflow Detected - VYM, JNJ, MRK, CME
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard High Dividend Yield ETF (Symbol: VYM) where we have detected an approximate $440.7 million dollar inflow -- that's a 0.7% increase week over - 2025-09-10 11:50:46
MRK Factor-Based Stock Analysis - Peter Lynch
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-10 10:34:14
Daiichi Sankyo And Merck : Ifinatamab Deruxtecan Shows Promising Results In Phase 2 ES-SCLC Trial
(RTTNews) - Daiichi Sankyo (DSKYF, 4568.T) and Merck & Co Inc. (MRK) announced that Results from the IDeate-Lung01 phase 2 trial showed that ifinatamab deruxtecan (I-DXd) demonstrated clinically meaningful response rates in patients with previously treated extensive-stage small c - 2025-09-08 02:18:22
Peter Lynch Detailed Fundamental Analysis - MRK
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-05 10:33:56
Pre-Market Most Active for Sep 5, 2025 : OPEN, TSLL, SCAG, SQQQ, MRK, NVDA, KO, AVGO, SNAP, FIG, WMT, NIO
The NASDAQ 100 Pre-Market Indicator is up 147.96 to 23,780.97. The total Pre-Market volume is currently 100,628,631 shares traded.The following are the most active stocks for the pre-market session: Opendoor Technologies Inc (OPEN) is +0.27 at $6.23, with 12,819,663 shares trade - 2025-09-05 09:29:53
Guru Fundamental Report for MRK - Peter Lynch
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-04 10:32:25
MRK Factor-Based Stock Analysis - Peter Lynch
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-03 10:34:47
Peter Lynch Detailed Fundamental Analysis - MRK
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-29 10:33:23
MRK's Strong Dividend History Helps it Reach 'Top Dividend Stock of the Dow'
Merck & Co Inc (Symbol: MRK) has been named as the ''Top Dividend Stock of the Dow'', according to Dividend Channel, which published its most recent ''DividendRank'' report. The report noted that among the components of the Dow Jones Industrial Average, MRK shares displayed b - 2025-08-28 08:50:04
MRK Factor-Based Stock Analysis - Peter Lynch
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-27 10:34:49
MRK Quantitative Stock Analysis - Peter Lynch
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-26 10:34:02
iShares MSCI ACWI ETF Experiences Big Outflow
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI ACWI ETF (Symbol: ACWI) where we have detected an approximate $429.5 million dollar outflow -- that's a 1.9% decrease week over week (f - 2025-08-25 13:36:45
Peter Lynch Detailed Fundamental Analysis - MRK
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-22 10:34:21
Dow Movers: WMT, MRK
In early trading on Thursday, shares of Merck topped the list of the day's best performing Dow Jones Industrial Average components, trading up 1.2%. Year to date, Merck has lost about 13.8% of its value. And the worst performing Dow component thus far on the day is Walmart, tr - 2025-08-21 11:27:42
MRK Factor-Based Stock Analysis - Peter Lynch
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-20 10:34:00
After Hours Most Active for Aug 19, 2025 : CSX, INTC, MRK, NVDA, IBN, KO, FUN, PEP, CX, WMT, HTZ, QQQ
The NASDAQ 100 After Hours Indicator is down -1.71 to 23,383.06. The total After hours volume is currently 259,932,235 shares traded.The following are the most active stocks for the after hours session: CSX Corporation (CSX) is -0.04 at $36.48, with 11,794,785 shares traded. Ove - 2025-08-19 17:24:59
Daiichi Sankyo Announces Breakthrough Therapy Designation For Ifinatamab Deruxtecan
(RTTNews) - Daiichi Sankyo announced that Ifinatamab deruxtecan has been granted Breakthrough Therapy Designation by the FDA for the treatment of adult patients with extensive-stage small cell lung cancer with disease progression on or after platinum-based chemotherapy. The FDA g - 2025-08-18 08:36:51
The Zacks Analyst Blog Highlights Merck, Palo Alto Networks, Freeport-McMoRan and Espey
Analysts spotlight Merck, Palo Alto Networks, Freeport-McMoRan, and Espey as innovation, contract wins, and industry trends shape growth prospects. - 2025-08-15 12:44:00
Noteworthy ETF Outflows: SUSL, MCD, DIS, MRK
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares ESG MSCI USA Leaders ETF (Symbol: SUSL) where we have detected an approximate $84.6 million dollar outflow -- that's a 8.7% decrease week ov - 2025-08-15 11:49:25
Peter Lynch Detailed Fundamental Analysis - MRK
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-15 10:31:59
Top Analyst Reports for Merck, Palo Alto & Freeport
Merck leans on Keytruda growth and pipeline expansion, Palo Alto rides subscription security demand, and Freeport benefits from electrification-driven copper demand. - 2025-08-14 17:46:00
Stocks See Support As Bessent Calls for a Big Rate Cut
The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 15:15:33
MRK April 2026 Options Begin Trading
Investors in Merck & Co Inc (Symbol: MRK) saw new options become available today, for the April 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 246 days until expiration the newly available contra - 2025-08-14 14:30:24
Stocks See Support As Bessent Calls for a Big Rate Cut
The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 14:05:26
Stocks See Support As Bessent Calls for a Big Rate Cut
The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 12:17:47

iShares Edge S&P 500 Minimum Volatility UCITS ETF USD (Dist) MRK holdings

DateNumber of MRK Shares HeldBase Market Value of MRK SharesLocal Market Value of MRK SharesChange in MRK Shares HeldChange in MRK Base ValueCurrent Price per MRK Share HeldPrevious Price per MRK Share Held
2025-11-11 (Tuesday)263,394MRK holding increased by 5278USD 23,955,684MRK holding increased by 1564121USD 23,955,6845,278USD 1,564,121 USD 90.95 USD 86.75
2025-11-10 (Monday)258,116MRK holding decreased by -5292USD 22,391,563MRK holding decreased by -335279USD 22,391,563-5,292USD -335,279 USD 86.75 USD 86.28
2025-11-07 (Friday)263,408MRK holding decreased by -4536USD 22,726,842MRK holding decreased by -257394USD 22,726,842-4,536USD -257,394 USD 86.28 USD 85.78
2025-11-06 (Thursday)267,944MRK holding increased by 4524USD 22,984,236MRK holding increased by 754222USD 22,984,2364,524USD 754,222 USD 85.78 USD 84.39
2025-11-05 (Wednesday)263,420USD 22,230,014MRK holding increased by 139613USD 22,230,0140USD 139,613 USD 84.39 USD 83.86
2025-11-04 (Tuesday)263,420MRK holding decreased by -369USD 22,090,401MRK holding increased by 330446USD 22,090,401-369USD 330,446 USD 83.86 USD 82.49
2025-11-03 (Monday)263,789USD 21,759,955MRK holding decreased by -920623USD 21,759,9550USD -920,623 USD 82.49 USD 85.98
2025-10-31 (Friday)263,789USD 22,680,578MRK holding decreased by -79137USD 22,680,5780USD -79,137 USD 85.98 USD 86.28
2025-10-30 (Thursday)263,789USD 22,759,715MRK holding decreased by -79137USD 22,759,7150USD -79,137 USD 86.28 USD 86.58
2025-10-29 (Wednesday)263,789USD 22,838,852MRK holding decreased by -118705USD 22,838,8520USD -118,705 USD 86.58 USD 87.03
2025-10-28 (Tuesday)263,789USD 22,957,557MRK holding decreased by -255875USD 22,957,5570USD -255,875 USD 87.03 USD 88
2025-10-27 (Monday)263,789MRK holding increased by 1508USD 23,213,432MRK holding increased by 266467USD 23,213,4321,508USD 266,467 USD 88 USD 87.49
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of MRK by Blackrock for IE00BD93YH54

Show aggregate share trades of MRK

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-11BUY5,27891.06587.260 87.641GBX 462,567 87.63
2025-11-10SELL-5,29287.37085.800 85.957GBX -454,884 87.64 Profit of 8,883 on sale
2025-11-07SELL-4,53686.57085.240 85.373GBX -387,252 87.64 Profit of 10,297 on sale
2025-11-06BUY4,52486.17084.350 84.532GBX 382,423 87.65
2025-11-04SELL-36984.96082.035 82.328GBX -30,379 87.69 Profit of 1,979 on sale
2025-10-27BUY1,50888.29587.030 87.157GBX 131,432 87.75
2025-10-22SELL-75488.79087.030 87.206GBX -65,753 87.75 Profit of 413 on sale
2025-10-20BUY2,26287.00085.030 85.227GBX 192,783 87.76
2025-10-15SELL-1,50884.69083.610 83.718GBX -126,247 87.82 Profit of 6,193 on sale
2025-10-14BUY75485.68084.150 84.303GBX 63,564 87.84
2025-10-03BUY74690.70088.100 88.360GBX 65,917 87.84
2025-09-30BUY37684.00078.400 78.960GBX 29,689 87.83
2025-09-25BUY37679.87577.600 77.827GBX 29,263 88.01
2025-07-16SELL-5,65582.64081.460 81.578GBX -461,324 88.33 Profit of 38,166 on sale
2025-07-14SELL-75484.30083.110 83.229GBX -62,755 88.40 Profit of 3,902 on sale
2025-07-11SELL-1,13184.13082.260 82.447GBX -93,248 88.44 Profit of 6,775 on sale
2025-07-10SELL-37985.00083.170 83.353GBX -31,591 88.47 Profit of 1,938 on sale
2025-07-09SELL-75484.48081.890 82.149GBX -61,940 88.50 Profit of 4,788 on sale
2025-07-03SELL-5,65582.60080.700 80.890GBX -457,433 88.55 Profit of 43,325 on sale
2025-07-02SELL-75082.79081.894 81.983GBX -61,487 88.59 Profit of 4,958 on sale
2025-06-27SELL-75879.54078.140 78.280GBX -59,336 88.73 Profit of 7,918 on sale
2025-06-23SELL-75680.22078.990 79.113GBX -59,809 88.98 Profit of 7,463 on sale
2025-06-20SELL-37879.92078.600 78.732GBX -29,761 89.06 Profit of 3,903 on sale
2025-06-18SELL-73080.31077.100 77.421GBX -56,517 89.20 Profit of 8,599 on sale
2025-06-16SELL-4,53481.35079.710 79.874GBX -362,149 89.34 Profit of 42,934 on sale
2025-06-13SELL-19,20482.44081.450 81.549GBX -1,566,067 89.40 Profit of 150,784 on sale
2025-06-12SELL-16,97282.11080.070 80.274GBX -1,362,410 89.46 Profit of 155,873 on sale
2025-06-11SELL-75681.68079.980 80.150GBX -60,593 89.53 Profit of 7,090 on sale
2025-06-06BUY1,13479.49078.210 78.338GBX 88,835 89.75
2025-06-05BUY1,51678.55077.250 77.380GBX 117,308 89.85
2025-05-28SELL-1,13177.72575.590 75.803GBX -85,734 90.49 Profit of 16,615 on sale
2025-05-27BUY1,13478.20077.050 77.165GBX 87,505 90.60
2025-05-23SELL-3,402 77.580* 90.82 Profit of 308,978 on sale
2025-05-22BUY75678.36076.680 76.848GBX 58,097 90.93
2025-05-20BUY3,40279.18077.422 77.597GBX 263,986 91.17
2025-05-16SELL-15076.16574.368 74.547GBX -11,182 91.42 Profit of 2,532 on sale
2025-05-15BUY1,512 74.800* 91.57
2025-05-14SELL-10,179 73.470* 91.74 Profit of 933,782 on sale
2025-05-13BUY754 76.630* 91.87
2025-05-12BUY1,877 80.430* 91.98
2025-05-09SELL-1,508 75.970* 92.13 Profit of 138,927 on sale
2025-05-08BUY1,131 77.650* 92.26
2025-05-07SELL-1,885 79.120* 92.39 Profit of 174,148 on sale
2025-04-30SELL-37685.83083.790 83.994GBX -31,582 92.87 Profit of 3,336 on sale
2025-04-28SELL-2,26283.68082.400 82.528GBX -186,678 93.05 Profit of 23,790 on sale
2025-04-23BUY37780.20078.240 78.436GBX 29,570 93.44
2025-04-15BUY4,91479.96077.720 77.944GBX 383,017 94.47
2025-04-14BUY75480.01078.360 78.525GBX 59,208 94.64
2025-04-09SELL-2,22081.99076.000 76.599GBX -170,050 95.17 Profit of 41,229 on sale
2025-04-08BUY1,11283.27077.540 78.113GBX 86,862 95.36
2025-04-04BUY2,22786.26081.090 81.607GBX 181,739 95.70
2025-04-02BUY1,077 86.600* 95.81
2025-04-01SELL-3,336 87.120* 95.92 Profit of 319,983 on sale
2025-03-31BUY17,512 89.760* 96.00
2025-03-28BUY2,224 89.230* 96.08
2025-03-27BUY4,343 87.600* 96.19
2025-03-26BUY11,085 88.110* 96.29
2025-03-25BUY7,574 87.870* 96.41
2025-03-24SELL-1,112 92.310* 96.46 Profit of 107,263 on sale
2025-03-21SELL-108,507 93.110* 96.51 Profit of 10,471,483 on sale
2025-03-19BUY1,561 94.020* 96.56
2025-03-17SELL-3,224 94.790* 96.62 Profit of 311,490 on sale
2025-03-14SELL-1,612 94.570* 96.65 Profit of 155,793 on sale
2025-03-13SELL-1,612 94.710* 96.67 Profit of 155,839 on sale
2025-03-12SELL-3,224 93.350* 96.72 Profit of 311,837 on sale
2025-03-07BUY4,833 94.650* 96.81
2025-02-28BUY4,83392.35090.710 90.874GBX 439,194 97.08
2025-02-26BUY6,44491.37088.860 89.111GBX 574,231 97.32
2025-02-21BUY9,66689.53087.010 87.262GBX 843,475 97.68
2025-02-18BUY3,22283.59081.040 81.295GBX 261,932 98.38
2025-02-11BUY8,05586.99085.730 85.856GBX 691,570 99.86
2025-02-07BUY3,22288.60087.120 87.268GBX 281,178 100.44
2025-02-06BUY1,61089.57187.840 88.013GBX 141,701 100.72
2025-02-05BUY4,83090.74087.995 88.270GBX 426,342 100.98
2025-02-04BUY1,61091.23087.330 87.720GBX 141,229 101.22
2025-01-31SELL-3,220100.06098.580 98.728GBX -317,904 101.32 Profit of 8,330 on sale
2025-01-29SELL-3,22099.15097.390 97.566GBX -314,163 101.46 Profit of 12,529 on sale
2025-01-02SELL-9,520100.35098.840 98.991GBX -942,394 102.08 Profit of 29,404 on sale
2024-12-10SELL-1,607103.770100.750 101.052GBX -162,391 102.11 Profit of 1,706 on sale
2024-12-09SELL-1,607105.070102.330 102.604GBX -164,885 102.06 Loss of -875 on sale
2024-11-27SELL-3,212103.450101.640 101.821GBX -327,049 101.98 Profit of 504 on sale
2024-11-21SELL-6,424100.48096.950 97.303GBX -625,074 102.30 Profit of 32,091 on sale
2024-11-20SELL-3,21098.84096.660 96.878GBX -310,978 102.57 Profit of 18,266 on sale
2024-11-18SELL-3,21097.29095.420 95.607GBX -306,898 103.32 Profit of 24,761 on sale
2024-11-12SELL-9,630100.76098.500 98.726GBX -950,731 103.64 Profit of 47,290 on sale
2024-11-08SELL-25,680103.230101.020 101.241GBX -2,599,869 103.69 Profit of 62,835 on sale
2024-11-07SELL-11,228101.690100.850 100.934GBX -1,133,287 103.88 Profit of 33,095 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MRK

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-191,053,2942,0243,869,11627.2%
2025-09-181,184,9228,0053,015,34039.3%
2025-09-171,616,76818,7303,647,85344.3%
2025-09-161,223,7119603,598,70934.0%
2025-09-151,814,7678,4204,295,96242.2%
2025-09-122,018,4637,5573,506,69457.6%
2025-09-111,493,7285,3993,180,82847.0%
2025-09-102,013,1025,3353,313,84760.7%
2025-09-091,075,1375,5052,373,81745.3%
2025-09-082,147,2042,4483,731,34357.5%
2025-09-051,440,1149,9482,983,29648.3%
2025-09-041,439,7261,1215,661,88725.4%
2025-09-031,849,1033,5534,699,60739.3%
2025-09-022,193,136115,1354,314,82650.8%
2025-08-291,545,05711,4203,841,71540.2%
2025-08-281,559,7666,1695,284,88829.5%
2025-08-271,383,4767,8383,737,50637.0%
2025-08-261,328,2351,2292,869,94446.3%
2025-08-252,177,2005,5783,771,31357.7%
2025-08-221,523,3527,4973,248,57546.9%
2025-08-212,449,66018,5405,416,96945.2%
2025-08-201,189,29116,6923,133,34538.0%
2025-08-191,722,6512,3313,737,68946.1%
2025-08-181,150,9372,8222,604,34444.2%
2025-08-151,795,3941,6733,415,80852.6%
2025-08-142,198,5622,2724,496,39848.9%
2025-08-131,885,48019,5373,953,04547.7%
2025-08-121,593,84410,3603,185,66750.0%
2025-08-11990,4053,6052,886,69034.3%
2025-08-081,224,37811,1872,672,27945.8%
2025-08-071,718,6615,3564,504,85038.2%
2025-08-062,028,9271,8824,007,25250.6%
2025-08-051,573,6816,0493,579,53444.0%
2025-08-041,568,9759443,301,80147.5%
2025-08-011,718,70113,8534,079,64242.1%
2025-07-313,367,7552,6646,082,64455.4%
2025-07-302,253,4585,8784,162,63654.1%
2025-07-295,939,07236,24911,111,79553.4%
2025-07-282,243,2356,7394,563,91349.2%
2025-07-251,302,4376,9002,889,20745.1%
2025-07-241,156,3972,5702,732,35142.3%
2025-07-231,879,40020,2804,001,02547.0%
2025-07-221,628,7541,7733,592,84745.3%
2025-07-211,900,56312,5715,188,43236.6%
2025-07-181,536,7621,2463,463,05944.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.